Event News & Resources
Neuro-Bio spotlight from Barclays Business Banking
With the help from and support from our local relationship managers, Barclays Business Banking, we're working on building our marketing portfolio and expanding the business internationally. We're extremely proud of the progress we're making in the fight against...
Neuro-Bio welcomes Amy-May Pointer
Neuro-Bio Ltd welcomes Amy-May Pointer as new Laboratory Manager. Amy-May graduated from the University of Nottingham with a Bachelor Honours degree in Microbiology. Her final-year research project focused on Extended-Spectrum Beta-Lactamases (ESBL) Producing...
Neuro-Bio’s paper on “International journal of Biochemistry and Biology”
Neuro-Bio's paper has been published on "International Journal of Biochemistry and Cell Biology" with the title WHEN A TROPHIC PROCESS TURNS TOXIC: ALZHEIMER’S DISEASE AS AN ABERRANT RECAPITULATION OF A DEVELOPMENTAL MECHANISM. Garcia-Ratés, Sara; Greenfield,...
Neuro-Bio’s article for the “European Biopharmaceutical Review”
Susan Greenfield, Founder and CEO of Neuro-Bio Ltd, shared her insights on the challenges of developing Alzheimer’s disease treatments, and the fundamental flaw with approaches to date on the "European Biopharmaceutical Review". To read the full article, click the...
Neuro-Bio’s CEO participates at the 8th EAN Congress in Vienna.
On Saturday the 25th of June, Neuro-Bio's CEO Susan Greenfield, will speak at the opening session of the EAN 2022 congress, the biggest meeting in Neurology! Her talk will be "Where Neuroscience meets neurology: blowing, expanding, and losing the mind". To watch the...
Neuro-Bio in the Australian “Financial Review”.
During her trip to Australia, Neuro-Bio's CEO, Susan Greenfield had an interview with Julie Hare, Education editor for the Australian "Financial Review". In April, Baroness Professor Greenfield published a research paper that proved a drug developed by her...
Neuro-Bio presenting at the AIMday- Translational Dementia Research 2022
On Monday the 30th of May, Neuro-Bio's operations director, Sara Garcia-Rates, will be presenting at virtual AIMday in Translational Dementia Research, hosted by the University of Oxford. Sara will be talking about Neuro-Bio’s research in a workshop from 10.15 to...